RYTM vs. STX
RYTM (Rhythm Pharmaceuticals, Inc.) and STX (Seagate Technology plc) are both stocks. RYTM operates in Biotechnology (Healthcare), while STX operates in Computer Hardware (Technology). Over the past 5 years, RYTM returned 35.88%/yr vs 62.01%/yr for STX. At a 0.20 correlation, their price movements are largely independent.
Performance
RYTM vs. STX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RYTM achieves a -17.43% return, which is significantly lower than STX's 238.67% return.
RYTM
- 1D
- 0.82%
- 1M
- -5.70%
- YTD
- -17.43%
- 6M
- -22.17%
- 1Y
- 40.24%
- 3Y*
- 70.57%
- 5Y*
- 35.88%
- 10Y*
- —
STX
- 1D
- 7.25%
- 1M
- 13.91%
- YTD
- 238.67%
- 6M
- 225.10%
- 1Y
- 648.03%
- 3Y*
- 149.80%
- 5Y*
- 62.01%
- 10Y*
- 51.08%
RYTM vs. STX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYTM Rhythm Pharmaceuticals, Inc. | -17.43% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | -14.58% | -7.50% | 25.20% |
STX Seagate Technology plc | 238.67% | 225.26% | 4.06% | 69.12% | -51.42% | 87.50% | 10.14% | 62.14% | -2.90% | 24.96% |
Correlation
The correlation between RYTM and STX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Oct 5, 2017 | 0.20 |
The correlation between RYTM and STX shifts across timeframes, from 0.09 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RYTM:
$6.01B
STX:
$212.28B
RYTM:
-$3.10
STX:
$10.58
RYTM:
26.75
STX:
19.01
RYTM:
732.99
STX:
193.86
RYTM:
$217.17M
STX:
$11.01B
RYTM:
$194.16M
STX:
$4.57B
RYTM:
-$182.86M
STX:
$2.59B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RYTM vs. STX — Risk / Return Rank
RYTM
STX
RYTM vs. STX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and Seagate Technology plc (STX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RYTM | STX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -9.48 | ||
| Sortino ratioReturn per unit of downside risk | -4.70 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.81 | -0.62 |
| Calmar ratioReturn relative to maximum drawdown | 1.14 | 31.15 | -30.01 |
| Martin ratioReturn relative to average drawdown | 2.64 | 90.13 | -87.50 |
Loading charts...
Drawdowns
RYTM vs. STX - Drawdown Comparison
The maximum RYTM drawdown since its inception was -92.10%, roughly equal to the maximum STX drawdown of -88.74%. Use the drawdown chart below to compare losses from any high point for RYTM and STX.
Loading charts...
Drawdown Indicators
| RYTM | STX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.10% | -88.74% | -3.36% |
Max Drawdown (1Y)Largest decline over 1 year | -35.54% | -21.00% | -14.54% |
Max Drawdown (3Y)Largest decline over 3 years | -35.54% | -40.00% | +4.46% |
Max Drawdown (5Y)Largest decline over 5 years | -85.49% | -56.99% | -28.50% |
Max Drawdown (10Y)Largest decline over 10 years | — | -56.99% | — |
Current DrawdownCurrent decline from peak | -24.86% | -1.03% | -23.83% |
Average DrawdownAverage peak-to-trough decline | -32.15% | -26.44% | -5.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.31% | 7.24% | +8.07% |
Volatility
RYTM vs. STX - Volatility Comparison
The current volatility for Rhythm Pharmaceuticals, Inc. (RYTM) is 11.87%, while Seagate Technology plc (STX) has a volatility of 19.61%. This indicates that RYTM experiences smaller price fluctuations and is considered to be less risky than STX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RYTM | STX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.87% | 19.61% | -7.74% |
Volatility (6M)Calculated over the trailing 6-month period | 36.41% | 50.59% | -14.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.20% | 64.18% | -6.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.39% | 44.86% | +31.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.57% | 42.27% | +29.30% |
Dividends
RYTM vs. STX - Dividend Comparison
RYTM has not paid dividends to shareholders, while STX's dividend yield for the trailing twelve months is around 0.31%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYTM Rhythm Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
STX Seagate Technology plc | 0.31% | 1.05% | 3.27% | 3.28% | 5.32% | 2.40% | 4.21% | 4.27% | 6.53% | 6.02% | 6.60% | 6.14% |
Financials
RYTM vs. STX - Financials Comparison
This section allows you to compare key financial metrics between Rhythm Pharmaceuticals, Inc. and Seagate Technology plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RYTM vs. STX - Profitability Comparison
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
STX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported a gross profit of 1.45B and revenue of 3.11B. Therefore, the gross margin over that period was 46.5%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
STX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported an operating income of 982.00M and revenue of 3.11B, resulting in an operating margin of 31.6%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
STX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported a net income of 748.00M and revenue of 3.11B, resulting in a net margin of 24.0%.
Frequently Asked Questions
RYTM and STX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
STX has higher volatility (19.61%) compared to RYTM (11.87%). In terms of maximum drawdown, RYTM dropped -92.10% vs STX's -88.74%.
STX currently has the higher Sharpe Ratio (10.19 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RYTM and STX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer